Covered recipient · General Payments record
MICHAEL HAMER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2020–2024
$3,533.56
- Reported across 189 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,069.12 | 52 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $650.68 | 33 |
| Genentech USA, Inc. | $71.19 | 3 |
| Biogen, Inc. | $55.21 | 3 |
| Amgen Inc. | $53.59 | 2 |
| ARGENX US, INC. | $31.56 | 1 |
| Teva Pharmaceuticals USA, Inc. | $25.65 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.25 | 1 |
| ACADIA Pharmaceuticals Inc | $24.07 | 1 |
| Lilly USA, LLC | $21.77 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $20.91 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.30 | 1 |
| ANI Pharmaceuticals, Inc. | $18.75 | 1 |
| Lundbeck LLC | $18.71 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $18.17 | 1 |
| Neurocrine BioSciences, Inc. | $14.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (52)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.22 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869175 | CMS |
| ABBVIE INC. | $12.41 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869177 | CMS |
| ABBVIE INC. | $31.68 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869179 | CMS |
| ABBVIE INC. | $28.21 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869181 | CMS |
| ABBVIE INC. | $32.66 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869183 | CMS |
| ABBVIE INC. | $33.59 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869185 | CMS |
| ABBVIE INC. | $33.43 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869187 | CMS |
| ABBVIE INC. | $7.84 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869189 | CMS |
| ABBVIE INC. | $28.40 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869191 | CMS |
| ABBVIE INC. | $28.45 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869193 | CMS |
| ABBVIE INC. | $25.99 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869195 | CMS |
| ABBVIE INC. | $5.52 | 05/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869197 | CMS |
| ABBVIE INC. | $30.55 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869199 | CMS |
| ABBVIE INC. | $25.63 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869201 | CMS |
| ABBVIE INC. | $6.25 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869203 | CMS |
| ABBVIE INC. | $21.64 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869205 | CMS |
| ABBVIE INC. | $12.37 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869207 | CMS |
| ABBVIE INC. | $24.81 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869209 | CMS |
| ABBVIE INC. | $11.26 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869211 | CMS |
| ABBVIE INC. | $10.10 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869213 | CMS |
| ABBVIE INC. | $26.43 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869215 | CMS |
| ABBVIE INC. | $8.04 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869217 | CMS |
| ABBVIE INC. | $11.52 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869219 | CMS |
| ABBVIE INC. | $19.83 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869221 | CMS |
| ABBVIE INC. | $24.91 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869223 | CMS |
| ABBVIE INC. | $21.07 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869225 | CMS |
| ABBVIE INC. | $7.94 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869227 | CMS |
| ABBVIE INC. | $27.26 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869229 | CMS |
| ABBVIE INC. | $14.06 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869231 | CMS |
| ABBVIE INC. | $19.52 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869233 | CMS |
| ABBVIE INC. | $23.33 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869235 | CMS |
| ABBVIE INC. | $11.44 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869237 | CMS |
| ABBVIE INC. | $11.32 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103869239 | CMS |
| ACADIA Pharmaceuticals Inc | $24.07 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147972850 | CMS |
| Amgen Inc. | $23.65 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115696880 | CMS |
| Amgen Inc. | $29.94 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115696888 | CMS |
| ANI Pharmaceuticals, Inc. | $18.75 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091140638 | CMS |
| ARGENX US, INC. | $31.56 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142125091 | CMS |
| Biogen, Inc. | $15.34 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104807455 | CMS |
| Biogen, Inc. | $20.13 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104865636 | CMS |
| Biogen, Inc. | $19.74 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104811875 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $18.17 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144450658 | CMS |
| Genentech USA, Inc. | $25.51 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133069801 | CMS |
| Genentech USA, Inc. | $24.64 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133069805 | CMS |
| Genentech USA, Inc. | $21.04 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133069809 | CMS |
| Lilly USA, LLC | $21.77 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135192485 | CMS |
| Lundbeck LLC | $18.71 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145922588 | CMS |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $20.91 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144507682 | CMS |
| Neurocrine Biosciences, Inc. | $14.31 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150876894 | CMS |
| Novartis Pharmaceuticals Corporation | $20.30 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086960267 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.25 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137569228 | CMS |
| Teva Pharmaceuticals USA, Inc. | $25.65 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151622023 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.